01548.HK
Genscript Biotech Corporation
HKSE · Healthcare · Biotechnology · CN
HKD 39.34
+5.70%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 1356.59x
- P/E 2027E
- 64.61x
- P/E 2028E
- 35.38x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.84x
- Price / sales
- 13.05x
- Price / cash flow
- 33.83x
Enterprise value
- Enterprise value
- HKD 81.9B
- EV / sales
- 12.37x
- EV / EBITDA
- 52.63x
- EV / EBIT
- 83.15x
- Market cap
- HKD 86.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026